Publication & Citation Trends
Publications
0 total
Final results: A dose escalation phase I study of ARQ 197, a selective c-Met inhibitor, in patients with metastatic solid tumors.
Cited by 27
Semantic Scholar
Discovery Medicine
Cited by 0
Semantic Scholar
Results of the X-PECT study: A phase III randomized double-blind, placebo-controlled study of perifosine plus capecitabine (P-CAP) versus placebo plus capecitabine (CAP) in patients (pts) with refractory metastatic colorectal cancer (mCRC).
Cited by 52
Semantic Scholar
Research Topics
Cancer Research and Treatments
(68)
Virus-based gene therapy research
(52)
RNA Interference and Gene Delivery
(28)
CAR-T cell therapy research
(27)
Cancer Treatment and Pharmacology
(21)
Affiliations
GenVec
Northwestern University
University of North Carolina at Chapel Hill
University of Maryland, Baltimore
Cedars-Sinai Medical Center
External Profiles
Continue on JournalsHub
Put what you just read into practice with these free tools.